Do tetracyclines have the potential to reduce the risk of Clostridium difficile infection?

References

• Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015 Feb 26;372(9):825–834. PubMed PMID: 25714160.
   PubMed Web of Science ®Google Scholar
• Goorhuis A, Van der Kooi T, Vaessen N, et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis. 2007 Sep 15;45(6):695–703. PubMed PMID: 17712752.
   PubMed Web of Science ®Google Scholar
• Smith A. Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US. Euro Surveill. 2005 Jun 30;10(6):E050630 2. PubMed PMID: 16783109.
   PubMedGoogle Scholar
• Meyer E, Gastmeier P, Weizel-Kage D, et al. Associations between nosocomial meticillin-resistant Staphylococcus aureus and nosocomial Clostridium difficile-associated diarrhoea in 89 German hospitals. J Hosp Infect. 2012 Nov;82(3):181–186. PubMed PMID: 23021304.
   PubMed Web of Science ®Google Scholar
• Nagy E. What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe? J Infect Chemother. 2017 Dec 27. PubMed PMID: 29289484.
   PubMedGoogle Scholar
• Tariq R, Khanna S. Clostridium difficile infection: updates in management. Indian J Gastroenterol. 2017 Jan;36(1):3–10. PubMed PMID: 27995486.
   PubMed Web of Science ®Google Scholar
• Tariq R, Pardi DS, Tosh PK, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection reduces recurrent urinary tract infection frequency. Clin Infect Dis. 2017 Oct 30;65(10):1745–1747. PubMed PMID: 29020210.
   PubMed Web of Science ®Google Scholar
• Khanna S, Pardi DS. Clinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile infection. Expert Rev Gastroenterol Hepatol. 2016 Mar 16:1–8. PubMed PMID: 26907220.
   PubMed Web of Science ®Google Scholar
• Jernberg C, Lofmark S, Edlund C, et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. Isme J. 2007 May;1(1):56–66. PubMed PMID: 18043614.
   PubMed Web of Science ®Google Scholar
• Deshpande A, Pasupuleti V, Thota P, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother. 2013 Sep;68(9):1951–1961. PubMed PMID: 23620467.
   PubMed Web of Science ®Google Scholar
• Doernberg SB, Winston LG, Deck DH, et al. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis. 2012 Sep;55(5):615–620. PubMed PMID: 22563022; PubMed Central PMCID: PMCPMC3491851.
   PubMed Web of Science ®Google Scholar
• Delaney JA, Dial S, Barkun A, et al. Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis. 2007 May;13(5):761–763. PubMed PMID: 17553260; PubMed Central PMCID: PMCPMC2738472.
   PubMed Web of Science ®Google Scholar
• Dunston CR, Griffiths HR, Lambert PA, et al. Proteomic analysis of the anti-inflammatory action of minocycline. Proteomics. 2011 Jan;11(1):42–51. PubMed PMID: 21182193; PubMed Central PMCID: PMCPMC3430857.
   PubMed Web of Science ®Google Scholar
• Joshi N, Miller DQ. Doxycycline revisited. Arch Intern Med. 1997 Jul 14;157(13):1421–1428. PubMed PMID: 9224219.
   PubMedGoogle Scholar
• https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050278s037lbl.pdf. [cited 2017 Nov 17].
   Google Scholar
• Noren T, Alriksson I, Akerlund T, et al. In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect. 2010 Aug;16(8):1104–1110. PubMed PMID: 19732094.
   PubMed Web of Science ®Google Scholar
• Barbut F, Mastrantonio P, Delmee M, et al. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect. 2007 Nov;13(11):1048–1057. PubMed PMID: 17850341.
   PubMed Web of Science ®Google Scholar
• Lin H, Jin D, Freitag TE, et al. A compositional shift in the soil microbiome induced by tetracycline, sulfamonomethoxine and ciprofloxacin entering a plant-soil system. Environ Pollut. 2016 May;212:440–448. PubMed PMID: 26952272.
   PubMed Web of Science ®Google Scholar
• Jump RL, Kraft D, Hurless K, et al. Impact of tigecycline versus other antibiotics on the fecal metabolome and on colonization resistance to Clostridium difficile in mice. Pathog Immun. 2017 Jan 18;2(1):1–20. PubMed PMID: 28217763; PubMed Central PMCID: PMCPMC5315001.
   PubMedGoogle Scholar
• Navalkele BD, Lerner SA. Intravenous tigecycline facilitates cure of severe Clostridium difficile infection (CDI) after failure of standard therapy: a case report and literature review of tigecycline use in CDI. Open Forum Infect Dis. 2016 Apr;3(2):ofw094. PubMed PMID: 27419166; PubMed Central PMCID: PMCPMC4943546.
   PubMed Web of Science ®Google Scholar
• Tariq R, Cho J, Kapoor S, et al. Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and metaanalysis. Clin Infect Dis. 2017. Epub ahead of print.
   PubMedGoogle Scholar
• Di Bella S, Taglietti F, Petrosillo N. Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia? Antimicrob Agents Chemother. 2013 Aug;57(8):4093. PubMed PMID: 23858063; PubMed Central PMCID: PMCPMC3719784.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(Suppl 2):S27–S72. PubMed PMID: 17278083.
   PubMed Web of Science ®Google Scholar